Author:
Knol Mirjam J.,Wagenvoort Gertjan H.J.,Sanders Elisabeth A.M.,Elberse Karin,Vlaminckx Bart J.,de Melker Hester E.,van der Ende Arie
Publisher
Centers for Disease Control and Prevention (CDC)
Subject
Infectious Diseases,Microbiology (medical),Epidemiology
Reference13 articles.
1. van Lier EA, Oomen PJ, Mulder M, Conyn-van Spaendonck MA, Drijfhout IH, de Hoogh PA, Vaccination coverage, National Immunization Program, the Netherlands; 2013 [in Dutch] [cited 2015 Jul 15]. http://www.rivm.nl/en/Documents_and_publications/Scientific/Reports/2013/juni/Immunisation_coverage_National_Immunisation_Programme_in_the_Netherlands_Year_of_report_2013
2. Invasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, the Netherlands.;van Deursen;Emerg Infect Dis,2012
3. Long-term effects of pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis.;Spijkerman;PLoS ONE,2012
4. Invasive pneumococcal diseases in birth cohorts vaccinated with PCV-7 and/or PHiD-CV in the province of Quebec, Canada.;De Wals;Vaccine,2012
5. Domingues CM, Verani JR, Montenegro Renoiner EI, de Cunto Brandileone MC, Flannery B, de Oliveira LH, Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case–control study. Lancet Respir Med. 2014;2:464–71.